You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ChemGenex Pharmaceuticals

Showing 1 - 25 of 474
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +28 more
Dec 1, 2021

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +31 more
Nov 11, 2021

Acne Vulgaris Trial in Hawthorne (Trifarotene Cream 0.005%, Placebo, AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories))

Completed
  • Acne Vulgaris
  • Trifarotene Cream 0.005%
  • +2 more
  • Hawthorne, New York
    Taro Pharmaceuticals USA Inc.
Sep 27, 2023

Healthy Trial in Jakarta (Dapagliflozin 10 mg film-coated tablet, Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca

Completed
  • Healthy
  • Dapagliflozin 10 mg film-coated tablet
  • Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia
  • Jakarta, Indonesia
    PT Equilab International
Nov 7, 2023

Allergic Asthma, Uncontrolled Moderate to Severe Trial in Iran, Islamic Republic of (Omalizumab (CinnaGen), Omalizumab

Completed
  • Allergic Asthma
  • Uncontrolled Moderate to Severe
  • Omalizumab (CinnaGen)
  • Omalizumab (Genentech, Inc., USA and Novartis Pharmaceuticals Corp, Switzerland)
  • Ahvaz, Iran, Islamic Republic of
  • +21 more
Apr 3, 2023

Metastatic Breast Cancer, Advanced Breast Cancer, HR-positive Breast Cancer Trial (OP-1250, Ribociclib, Alpelisib)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • (no location specified)
Aug 18, 2022

Gender Trial ([18F]MC225)

Not yet recruiting
  • Gender
  • (no location specified)
Nov 8, 2022

Healthy Volunteers Trial (Capoten, Captopril)

Withdrawn
  • Healthy Volunteers
  • (no location specified)
Jan 25, 2023

MDD Trial in New York, Houston (XEN1101, Placebo)

Recruiting
  • Major Depressive Disorder
  • New York, New York
  • +1 more
Nov 8, 2022

Resistant Epilepsy, Drug, Adolescent Epilepsy, Children Epilepsy Trial in Petach Tikvah, Ljubljana (MGCND00EP1, Placebo, ECG)

Not yet recruiting
  • Resistant Epilepsy, Drug
  • +3 more
  • Petach Tikvah, Central District, Israel
  • +1 more
Aug 23, 2022

Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets

Active, not recruiting
  • Partial Seizure
  • Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Municipal People's Hospital
Jan 31, 2023

Asthma Trial in Athens (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR

Not yet recruiting
  • Asthma
  • Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
  • +2 more
  • Athens, Greece
    BECRO Ltd.
Jan 20, 2023

Plaque Psoriasis Trial (mometasone furoate + salicylic acid, Mometasone furoate)

Suspended
  • Plaque Psoriasis
  • mometasone furoate + salicylic acid
  • Mometasone furoate
  • (no location specified)
Nov 1, 2022

Adolescent Idiopathic Scoliosis Trial in Baltimore (AbobotulinumtoxinA, Placebos, Custom Thoracolumbosacral Orthosis)

Recruiting
  • Adolescent Idiopathic Scoliosis
  • Baltimore, Maryland
    Johns Hopkins University
Sep 12, 2022

Motion Sickness, Space, Motion Sickness, Sea Sickness Trial in Houston (DPI-386 Nasal Gel, Placebo Nasal Gel)

Recruiting
  • Motion Sickness, Space
  • +2 more
  • DPI-386 Nasal Gel
  • Placebo Nasal Gel
  • Houston, Texas
    NASA Johnson Space Center Neuroscience Laboratory
May 23, 2023

Overactive Bladder Syndrome Trial run by the Walter Reed National Military Medical Center (Xeomin 100 UNT Injection, Botox 100

Recruiting
  • Overactive Bladder Syndrome
  • Xeomin 100 UNT Injection
  • Botox 100 UNT Injection
  • Bethesda, Maryland
    Walter Reed National Military Medical Center
Sep 5, 2023

[18F]FPSMA-1007 PET/CT in Suspected Prostate Cancer Patient

Not yet recruiting
  • Prostate Cancer
  • Prostate Neoplasm
  • Taichung, Taiwan
  • +1 more
Jun 16, 2022

Cardiac Conditions Trial in Miami (Bupivacaine liposome)

Recruiting
  • Cardiac Conditions
  • Bupivacaine liposome
  • Miami, Florida
    Nickalus Children's Hospital f/k/a Miami Children's Hospital
Apr 4, 2022

Healthy Trial in Iowa City (Lidocaine 5% patch, Lidocaine HCl, Lidoderm 5% patch)

Completed
Has Results
  • Healthy
  • Lidocaine 5% patch
  • +2 more
  • Iowa City, Iowa
    University of Iowa
Oct 1, 2021

Bronchial Asthma Trial in India (Fluticasone propionate Inhalation Aerosol 44 mcg, FLOVENT HFA 44 mcg, Matching Placebo inhaler)

Recruiting
  • Bronchial Asthma
  • Fluticasone propionate Inhalation Aerosol 44 mcg
  • +2 more
  • Ahmedabad, Gujarat, India
  • +10 more
May 24, 2022

Infertility, Female Trial in Bani Suwayf (Sildenafil Citrate, Clomiphene Citrate 50mg)

Completed
  • Infertility, Female
  • Sildenafil Citrate
  • Clomiphene Citrate 50mg
  • Banī Suwayf, Egypt
    Beni-suef university
Apr 26, 2023

Hypertension Trial in Dongguan (Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release

Active, not recruiting
  • Hypertension
  • Felodipine sustained release tablets (trade name: plendil®)
  • Felodipine Controlled Release Tablets
  • Dongguan, Guangdong, China
    Clinical Trial Centre of Dongguan Kanghua Hospital
Jan 31, 2023

Plaque Psoriasis Trial in Charlotte (Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%, Duobrii® Lotion (Halobetasol

Completed
  • Plaque Psoriasis
  • Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%
  • +2 more
  • Charlotte, North Carolina
    Catawba Research, LLC
Mar 15, 2022

To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 850/50 mg)

Completed
  • To Determine Bioequivalence Under Fed Conditions
  • Metformin and Vildagliptin 850/50 mg
  • (no location specified)
Apr 16, 2022

To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 1000/50 mg)

Completed
  • To Determine Bioequivalence Under Fed Conditions
  • Metformin and Vildagliptin 1000/50 mg
  • (no location specified)
Apr 14, 2022